Stocks To Watch Ampliphi Biosciences Stock 770% Upside From Current PriceJanuary 14, 2018 by Lance Jepsen Ampliphi Biosciences stock has rising large players volume after the company released incredible phase 1 trial results from their phage therapy cure for antibiotic resistant superbugs. SUBSCRIBE OR SIGN IN Login Biotechnology and Medical Research Healthcare